Company: NCEL
Filing Date: 2025-07-29
Form Type: F-4/A
Source: 0001213900-25-068765
Chunk: 724

Company: NewcelX Ltd.
Filing Date: 2025-07-29
Form: F-4/A
Chunk 724
---
 amount of CHF 72,540, for which the creditor Ronald Hafner is entitled to 14,121 registered shares (common shares) with a par value of CHF 0.80 per share;                     
 Offsetting in the amount of CHF 15,435, for which the creditor Florence Allouche is entitled to 3,005 registered shares (common shares) with a par value of CHF 0.80 per share;                  
 Offsetting in the amount of CHF 372,171, for which the creditor Alexander Zwyer is entitled to 72,446 registered shares (common shares) with a par value of CHF 0.80 per share;                  
 Offsetting in the amount of CHF 21,247.20, for which the creditor George Apostol is entitled to 4,136 registered shares (common shares) with a par value of CHF 0.80 per share;                  
 Offsetting in the amount of USD 19,159.32, for which the creditor KEY-OBS SAS is entitled to 3,394 registered shares (common shares) with a par value of CHF 0.80 per share;                     
 Offsetting in the amount of USD 130,000, for which the creditor Aexon Labs Inc. is entitled to 23,028 registered shares (common shares) with a par value of CHF 0.80 per share;                  
 Offsetting in the amount of USD 31,250, for which the creditor Jeff Bernier will receive 5,536 registered shares (common shares) with a par value of CHF 0.80 per share;                         |

Annex D-20

| Verrechnung im Betrage von USD 279’299.90, wofür der Gläubigerin CliniLabs Inc. 49’475 Namenaktien (Stammaktien) mit einem Nennwert von CHF 0.80 je Aktie zukommen;          
 Verrechnung im Betrage von USD 19’797.72, wofür dem Gläubiger Thomas Curatolo 3’507 Namenaktien (Stammaktien) mit einem Nennwert von CHF 0.80 je Aktie zukommen;             
 Verrechnung im Betrage von USD 12’500, wofür der Gläubigerin Jennifer Franco 2’215 Namenaktien (Stammaktien) mit einem